J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 586, Number 8, 2049-2060, April 15, 2008 DOI: 10.1113/jphysiol.2007.148346
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
586/8/2049    most recent
jphysiol.2007.148346v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Bender, K.
Right arrow Articles by Kienitz, M.-C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bender, K.
Right arrow Articles by Kienitz, M.-C.
Related Collections
Right arrow Cellular

CELLULAR

A role for RGS10 in β-adrenergic modulation of G-protein-activated K+ (GIRK) channel current in rat atrial myocytes

Kirsten Bender1, Parastoo Nasrollahzadeh1, Mathias Timpert1, Bing Liu1, Lutz Pott1 and Marie-Cécile Kienitz1

1 Institute of Physiology, Ruhr-University Bochum, D-44780 Bochum, Germany

The effect of β-adrenergic stimulation on endogenous G-protein-activated K+ (GIRK) current has been investigated in atrial myocytes from hearts of adult rats. β-Adrenergic stimulation (10 µM isoprenaline, Iso) had no effect on activation kinetics, peak current or steady-state current but resulted in slowing of deactivation upon washout of acetylcholine (ACh), the time constant ({tau}d) being increased by a factor of about 2.5. The effect of Iso could be mimicked by inclusion of cAMP (500 µM) in the filling solution of the patch clamp pipette. The Iso-induced increase in {tau}d was blocked by the selective β1 receptor antagonist CGP-20112A (2 µM) and by the PKA inhibitor H9 (100 µM included in the pipette solution). A candidate for mediating these effects is RGS10, one of the regulators of G-protein signalling (RGS) species expressed in cardiac myocytes. Overexpression of RGS10 by adenoviral gene transfer resulted in a reduction in {tau}d of 60%. Sensitivity of {tau}d to Iso remained in cells overexpressing RGS10. Overexpression of RGS4 caused a comparable reduction in {tau}d, which became insensitive to Iso. Expression of an RGS10 carrying a mutation (RGS10-S168A), which deletes a PKA phosphorylation site, caused a decrease in {tau}d comparable to overexpression of wild-type RGS10. Sensitivity of {tau}d to Iso was lost in RGS10-S168A-expressing myocytes. Silencing of RGS10 by means of adenovirus-mediated transcription of a short hairpin RNA did not affect basal {tau}d but removed sensitivity to Iso. These data suggest that endogenous RGS10 has GTPase-activating protein (GAP) activity on the G-protein species that mediates activation of atrial GIRK channels. Moreover, RGS10, via PKA-dependent phosphorylation, enables a crosstalk between β-adrenergic and muscarinic cholinergic signalling.

(Received 20 November 2007; accepted after revision 14 February 2008; first published online 14 February 2008)
Corresponding author L. Pott: Institute of Physiology, Ruhr-University Bochum, D-44780 Bochum, Germany. Email: lutz.pott{at}rub.de







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 The Physiological Society.